Earnings Feed
Start Free
BIOMARIN PHARMACEUTICAL INC·4

Mar 20, 5:13 PM ET

Slamon Dennis 4

4 · BIOMARIN PHARMACEUTICAL INC · Filed Mar 20, 2024

Insider Transaction Report

Form 4
Period: 2024-03-18
BIOMARIN PHARMACEUTICAL INCBMRN
Slamon Dennis
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2024-03-18$79.70/sh+10,000$797,000→ 40,809 total
  • Exercise/Conversion

    Stock Option (Right to Buy Common Stock)

    2024-03-18−10,000→ 0 total
    Exercise: $79.70From: 2014-07-19Exp: 2024-03-18→ Common Stock (10,000 underlying)
  • Tax Payment

    Common Stock

    2024-03-18$83.81/sh−9,510$797,033→ 31,299 total
Footnotes (1)
  • [F1]Reflects the number of options outstanding after the transaction from this specific stock option grant.

Documents

3 files